Bioactive Substances, Oxidative Stress, and Inflammation, 2nd Edition
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: 25 December 2025 | Viewed by 20
Special Issue Editors
Interests: clinical trials; oxidative stress; bioavailability; bioactive compounds; inflammation; endothelial damage markers
Special Issues, Collections and Topics in MDPI journals
Interests: oxidative stress; bioavailability; ellagitanins; bioactive compounds; microbiota; inflammation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic inflammation generates reactive oxygen species (ROS) that contribute to the pathogenesis of chronic non-communicable diseases (cancer, cardiovascular diseases, autoimmune diseases, and metabolic syndrome, among others).
Bioactive compounds, including polyphenols, vitamins, omega-3 fatty acids, organic acids, nucleosides and nucleotides, and phytosterols, have attracted great attention due to their role in preventing and even treating pathologies involving oxidative stress and inflammation.
The aim of this issue is to increase knowledge on how bioactive compounds can ameliorate inflammation and oxidative stress. Authors are invited to submit original articles, reviews, systematic reviews, or meta-analyses for the identification of bioactive compounds with biological or clinical relevance in the processes of inflammation and oxidative stress in chronic non-communicable diseases.
Dr. Pilar Zafrilla
Dr. Begoña Cerdá
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioactive compounds
- oxidative stress
- chronic inflammation
- chronic non-communicable diseases
- polyphenol
- vitamins
- omega-3 fatty acids
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
